Clinical Trial Update: Glucose Counterregulation in Long Standing Type 1 Diabetes [NA]

View source ↗

Summary

A completed clinical trial from University of Pennsylvania studied glucose counterregulation in long-standing Type 1 diabetes, with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia Unawareness
• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of Pennsylvania | Conditions: Hypoglycemia Unawareness, Type 1 Diabetes | NA | Status: COMPLETED | Results posted: 2023-08-31